Physician profile
Andrew Kalin
NPI 1811100043
$11,839.08
in general payments reported to CMS, 2019-2025
28 companies · $640 in 2025
The $640 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,791 · 2020: $1,981 · 2021: $631 · 2022: $298 · 2023: $4,844 · 2024: $655 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,922 · Travel and Lodging: $2,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,922.11 |
| Travel and Lodging | $2,216.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $4,571.06 | 2023-2025 | Evoke Scs, Evoke |
| Abbott Laboratories | $2,726.09 | 2019-2023 | Proclaim |
| Boston Scientific Corporation | $1,481.54 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $957.10 | 2019-2022 | |
| Stryker Corporation | $316.09 | 2022-2025 | Mild Device Kit, Optablate, Omnicurve |
| Biotronik Nro, INC. | $288.88 | 2024 | Prospera |
| Medtronic, INC. | $231.96 | 2021-2025 | Osteocool Rf Ablation System, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Collegium Pharmaceutical, INC. | $215.80 | 2019-2020 | |
| Mml US, INC. | $169.28 | 2024 | Reactiv8 |
| Spr Therapeutics, INC | $140.83 | 2023 | Sprint Pns System |
| Pfizer INC. | $132.43 | 2019 | |
| Nalu Medical, INC. | $121.26 | 2023 | Nalu Neurostimulation System |
| Grt US Holding, INC. | $92.52 | 2022 | |
| Si-Bone, INC. | $69.29 | 2019 | |
| Sentynl Therapeutics, INC. | $55.06 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $42.84 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.31 | 2019 | |
| Zyla Life Sciences, INC. | $28.76 | 2020 | |
| Allergan, INC. | $25.73 | 2019 | |
| Assertio Therapeutics, INC. | $24.83 | 2019 | |
| Orthofix Medical, INC. | $24.57 | 2019 | |
| Avanos Medical | $15.16 | 2020 | |
| Vertiflex, INC. | $14.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.69 | 2019 | |
| Scilex Pharmaceuticals INC. | $13.62 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.74 | 2020 | |
| Biodelivery Sciences International, INC. | $11.44 | 2019 | |
| Stimwave Technologies Incorporated | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Kalin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.